Showing results (1-10 of 253) with videos related to
Sort By:
Pageof 26
Kidney International. Supplement|October 16, 2004
Beneficial impact on cardiovascular risk factors by dual blockade of the renin-angiotensin system in diabetic nephropathyPeter Jacobsen, Hans-Henrik ParvingNature Reviews. Nephrology|December 10, 2014
Diabetic nephropathy in 2014: improved cardiorenal prognosis in diabetic nephropathyHans-Henrik Parving, Peter RossingCurrent Hypertension Reports|September 10, 2002
Microalbuminuria in type 1 and type 2 diabetes mellitus: evidence with angiotensin converting enzyme inhibitors and angiotensin II receptor blockers for treating early and preventing clinical nephropathyHans-Henrik Parving, Peter HovindCurrent Hypertension Reports|September 3, 2004
Remission and regression of diabetic nephropathyPeter Hovind, Lise Tarnow, Hans-Henrik ParvingBritish Journal of Clinical Pharmacology|January 3, 2013
Direct renin inhibition in chronic kidney diseaseFrederik Persson, Peter Rossing, Hans-Henrik ParvingCurrent Opinion in Nephrology and Hypertension|April 10, 2004
Single versus dual blockade of the renin-angiotensin system (angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers) in diabetic nephropathyPeter Jacobsen, Kasper Rossing, Hans-Henrik ParvingDiabetes Research and Clinical Practice|December 4, 2014
Microalbuminuria: a parameter that has changed diabetes careHans-Henrik Parving, Frederik Persson, Peter RossingDiabetes Care|April 30, 2002
Risk factors for development of incipient and overt diabetic nephropathy in type 1 diabetic patients: a 10-year prospective observational studyPeter Rossing, Philip Hougaard, Hans-Henrik ParvingDiabetes Care|November 25, 2003
Kidney function during and after withdrawal of long-term irbesartan treatment in patients with type 2 diabetes and microalbuminuriaSteen Andersen, Jens Bröchner-Mortensen, Hans-Henrik Parving, et al.Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|August 23, 2005
Elevated placental growth factor (PlGF) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathyLise Tarnow, Anne Sofie Astrup, Hans-Henrik ParvingPageof 26